Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > results are good

<< Previous

Bullboard Posts

Next >>

Post by DJDawgon Nov 29, 2021 6:09pm

442 Views

Post# 34177774

results are good

For the 13 patient's who have ever recieved the fully optimized treatment and procedure, for which we have 90 day results

2 from ph1b - CR at 90 day
8 from phase 2 CR
2 from phase 2 PR
1 NR from phase 2
(7 pending)

Our optimized CR+PR is now 92% for which the range of error for a hypothetical population is 65% to 100% at 90 days.

I'll let Enrique and others digest more and extract more that I could ever.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments